(Updated - December 16, 2024 6:43 AM EST)

H.C. Wainwright analyst Matthew Caufield initiates coverage on Zenas Biopharma (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE